A regulatory role for protease-activated receptor-2 in motivational learning in rats

Neurobiology of Learning and Memory

Volumn 92, Issue 3, 2009, Pages 301-309

  Lohman, Rink Jan ^a   Jones, Nigel C ^a   O'Brien, Terence J ^a   Cocks, Thomas M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Anxiety; Cerebrospinal fluid; Elevated plus maze; Learning; Memory; Morris water maze; PAR2; Protease; Protease activated receptor 2; SLIGRL; Trypsin

Indexed keywords

PROTEINASE ACTIVATED RECEPTOR 2;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEPRESSION; HIPPOCAMPUS; LEARNING; MALE; MAZE TEST; MEMORY CONSOLIDATION; MEMORY DISORDER; MOTIVATION; NERVE CELL PLASTICITY; NONHUMAN; OPEN FIELD TEST; RAT; SUGAR INTAKE;

ANIMALS; ANXIETY; AVOIDANCE LEARNING; DRINKING BEHAVIOR; FEAR; HIPPOCAMPUS; LEARNING; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MOTIVATION; NEURONAL PLASTICITY; OLIGOPEPTIDES; RATS; RATS, INBRED STRAINS; RECEPTOR, PAR-2; SUCROSE; TIME FACTORS;

EID: 69249229554     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nlm.2009.03.010     Document Type: Article

References (66)

1. Abey H.T., Fairlie D.P., Moffatt J.D., Balzary R.W., and Cocks T.M. Protease-activated receptor-2 peptides activate neurokinin-1 receptors in the mouse isolated trachea. Journal of Pharmacology and Experimental Therapeutics 317 (2006) 598-605
2. Afkhami-Goli A., Noorbakhsh F., Keller A.J., Vergnolle N., Westaway D., Jhamandas J.H., et al. Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease. Journal of Immunology 179 (2007) 5493-5503
3. Albrechet-Souza L., Cristina de Carvalho M., Rodrigues Franci C., and Brandao M.L. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam. Hormones and Behavior 52 (2007) 267-273
4. Almonte A.G., Hamill C.E., Chhatwal J.P., Wingo T.S., Barber J.A., Lyuboslavsky P.N., et al. Learning and memory deficits in mice lacking protease activated receptor-1. Neurobiology of Learning and Memory (2007)
5. Alshurafa H.N., Stenton G.R., Wallace J.L., Hollenberg M.D., Befus A.D., and Vliagoftis H. A protease activated receptor-2 (PAR-2) activating peptide, tc-LIGRLO-NH2, induces protease release from mast cells: Role in TNF degradation. BMC Pharmacology 4 (2004) 12
6. Andreatini R., and Bacellar L.F. Animal models: Trait or state measure? The test-retest reliability of the elevated plus-maze and behavioral despair. Progress in Neuro-Psychopharmacology and Biological Psychiatry 24 (2000) 549-560
7. Bahi A., and Dreyer J.L. Overexpression of plasminogen activators in the nucleus accumbens enhances cocaine-, amphetamine- and morphine-induced reward and behavioral sensitization. Genes, Brain and Behavior (2007)
8. Barbosa P.R., Valvassori S.S., Bordignon Jr. C.L., Kappel V.D., Martins M.R., Gavioli E.C., et al. The aqueous extracts of Passiflora alata and Passiflora edulis reduce anxiety-related behaviors without affecting memory process in rats. Journal of Medicinal Food 11 (2008) 282-288
9. Bennur S., Shankaranarayana Rao B.S., Pawlak R., Strickland S., McEwen B.S., and Chattarji S. Stress-induced spine loss in the medial amygdala is mediated by tissue-plasminogen activator. Neuroscience 144 (2007) 8-16
10. Bertoglio L.J., and Carobrez A.P. Scopolamine given pre-trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze trial 2. Behavioural Pharmacology 15 (2004) 45-54
11. Cacquevel M., Launay S., Castel H., Benchenane K., Cheenne S., Buee L., et al. Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms. Neurobiology of Disease 27 (2007) 164-173
12. Calabresi P., Napolitano M., Centonze D., Marfia G.A., Gubellini P., Teule M.A., et al. Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. European Journal of Neuroscience 12 (2000) 1002-1012
13. Carey R.J., Damianopoulos E.N., and Shanahan A.B. Cocaine conditioned behavior: A cocaine memory trace or an anti-habituation effect. Pharmacology, Biochemistry and Behavior (2008)
14. Carobrez A.P., and Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on. Neuroscience and Biobehavioral Reviews 29 (2005) 1193-1205
15. Centonze D., Napolitano M., Saulle E., Gubellini P., Picconi B., Martorana A., et al. Tissue plasminogen activator is required for corticostriatal long-term potentiation. European Journal of Neuroscience 16 (2002) 713-721
16. Cruz-Morales S.E., Santos N.R., and Brandao M.L. One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat. Pharmacology, Biochemistry and Behavior 72 (2002) 973-978
17. DiNicolantonio R., Mendelsohn F.A., Hutchinson J.S., Rawlyk K., Shelton J., and Doyle A.E. Impaired angiotensin-induced drinking in spontaneously hypertensive rats. Life Sciences 31 (1982) 1051-1057
18. Espejo E.F. Effects of weekly or daily exposure to the elevated plus-maze in male mice. Behavioural Brain Research 87 (1997) 233-238
19. Gingrich M.B., Junge C.E., Lyuboslavsky P., and Traynelis S.F. Potentiation of NMDA receptor function by the serine protease thrombin. Journal of Neuroscience 20 (2000) 4582-4595
20. Haqqani A.S., Nesic M., Preston E., Baumann E., Kelly J., and Stanimirovic D. Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS. FASEB Journal 19 (2005) 1809-1821
21. Hirota M., Ohmuraya M., and Baba H. The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravation of pancreatitis. Journal of Gastroenterology 41 (2006) 832-836
22. Ito M., Nagai T., Mizoguchi H., Fukakusa A., Nakanishi Y., Kamei H., et al. Possible involvement of protease-activated receptor-1 in the regulation of morphine-induced dopamine release and hyperlocomotion by the tissue plasminogen activator-plasmin system. Journal of Neurochemistry 101 (2007) 1392-1399
23. Jones N.C., Salzberg M.R., Kumar G., Couper A., Morris M.J., and O'Brien T.J. Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation. Experimental Neurology 209 (2008) 254-260
24. Kawabata A., Matsunami M., and Sekiguchi F. Gastrointestinal roles for proteinase-activated receptors in health and disease. British Journal of Pharmacology 153 Suppl. 1 (2008) S230-S240
25. Kim M.H., Choi B.H., Jung S.R., Sernka T.J., Kim S., Kim K.T., et al. Protease-activated receptor-2 increases exocytosis via multiple signal transduction pathways in pancreatic duct epithelial cells. Journal of Biological Chemistry 283 (2008) 18711-18720
26. Komai S., Matsuyama T., Matsumoto K., Kato K., Kobayashi M., Imamura K., et al. Neuropsin regulates an early phase of schaffer-collateral long-term potentiation in the murine hippocampus. European Journal of Neuroscience 12 (2000) 1479-1486
27. Lamprea M.R., Cardenas F.P., Silveira R., Morato S., and Walsh T.J. Dissociation of memory and anxiety in a repeated elevated plus maze paradigm: Forebrain cholinergic mechanisms. Behavioural Brain Research 117 (2000) 97-105
28. Lee H.Y., Hwang I.Y., Im H., Koh J.Y., and Kim Y.H. Non-proteolytic neurotrophic effects of tissue plasminogen activator on cultured mouse cerebrocortical neurons. Journal of Neurochemistry 101 (2007) 1236-1247
29. Li D., Wang Q., Yuan Z.F., Zhang L., Xu L., Cui Y., et al. Pharmacokinetics and tissue distribution study of orientin in rat by liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 47 (2008) 429-434
30. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 46 (2001) 3-26
31. Lohman R.J., O'Brien T.J., and Cocks T.M. Protease-activated receptor-2 regulates trypsin expression in the brain and protects against seizures and epileptogenesis. Neurobiology of Disease 30 (2008) 84-93
32. Madani R., Hulo S., Toni N., Madani H., Steimer T., Muller D., et al. Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice. EMBO Journal 18 (1999) 3007-3012
33. Madani R., Kozlov S., Akhmedov A., Cinelli P., Kinter J., Lipp H.P., et al. Impaired explorative behavior and neophobia in genetically modified mice lacking or overexpressing the extracellular serine protease inhibitor neuroserpin. Molecular and Cellular Neurosciences 23 (2003) 473-494
34. Malhotra B.K., Lemaire M., and Sawchuk R.J. Investigation of the distribution of EAB 515 to cortical ECF and CSF in freely moving rats utilizing microdialysis. Pharmaceutical Research 11 (1994) 1223-1232
35. Mannaioni G., Orr A.G., Hamill C.E., Yuan H., Pedone K.H., McCoy K.L., et al. Plasmin potentiates synaptic N-methyl-d-aspartate receptor function in hippocampal neurons through activation of protease-activated receptor-1. Journal of Biological Chemistry 283 (2008) 20600-20611
36. Matys T., and Strickland S. Tissue plasminogen activator and NMDA receptor cleavage. Nature Medicine 9 (2003) 371-372 (author reply 372-373)
37. Meighan P.C., Meighan S.E., Davis C.J., Wright J.W., and Harding J.W. Effects of matrix metalloproteinase inhibition on short- and long-term plasticity of schaffer collateral/CA1 synapses. Journal of Neurochemistry (2007)
38. Melchor J.P., and Strickland S. Tissue plasminogen activator in central nervous system physiology and pathology. Thrombosis and Haemostasis 93 (2005) 655-660
39. Mhatre M., Nguyen A., Kashani S., Pham T., Adesina A., and Grammas P. Thrombin, a mediator of neurotoxicity and memory impairment. Neurobiology of Aging 25 (2004) 783-793
40. Mitra R., Jadhav S., McEwen B.S., Vyas A., and Chattarji S. Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 9371-9376
41. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods 11 (1984) 47-60
42. Nagai T., Ito M., Nakamichi N., Mizoguchi H., Kamei H., Fukakusa A., et al. The rewards of nicotine: Regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1. Journal of Neuroscience 26 (2006) 12374-12383
43. Nagy V., Bozdagi O., and Huntley G.W. The extracellular protease matrix metalloproteinase-9 is activated by inhibitory avoidance learning and required for long-term memory. Learning and Memory 14 (2007) 655-664
44. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., et al. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. Journal of Neuroscience 26 (2006) 1923-1934
45. Noorbakhsh F., Vergnolle N., McArthur J.C., Silva C., Vodjgani M., Andrade-Gordon P., et al. Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection. Journal of Immunology 174 (2005) 7320-7329
46. Pang P.T., and Lu B. Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: Role of secreted proteins tPA and BDNF. Ageing Research Reviews 3 (2004) 407-430
47. Pawlak R., Magarinos A.M., Melchor J., McEwen B., and Strickland S. Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. Nature Neuroscience 6 (2003) 168-174
48. Pawlak R., Rao B.S., Melchor J.P., Chattarji S., McEwen B., and Strickland S. Tissue plasminogen activator and plasminogen mediate stress-induced decline of neuronal and cognitive functions in the mouse hippocampus. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 18201-18206
49. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 5th ed. (2005), Elsevier Academic Press, Sydney
50. Prut L., and Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: A review. European Journal of Pharmacology 463 (2003) 3-33
51. Samson A.L., and Medcalf R.L. Tissue-type plasminogen activator: A multifaceted modulator of neurotransmission and synaptic plasticity. Neuron 50 (2006) 673-678
52. Sarkisova K.Y., Midzianovskaia I.S., and Kulikov M.A. Depressive-like behavioral alterations and c-fos expression in the dopaminergic brain regions in WAG/Rij rats with genetic absence epilepsy. Behavioural Brain Research 144 (2003) 211-226
53. Schmitt U., Hiemke C., Fahrenholz F., and Schroeder A. Over-expression of two different forms of the alpha-secretase ADAM10 affects learning and memory in mice. Behavioural Brain Research 175 (2006) 278-284
54. Sharma A., Tao X., Gopal A., Ligon B., Andrade-Gordon P., Steer M.L., et al. Protection against acute pancreatitis by activation of protease-activated receptor-2. American Journal of Physiology - Gastrointestinal and Liver Physiology 288 (2005) G388-G395
55. Sherwood M.W., Prior I.A., Voronina S.G., Barrow S.L., Woodsmith J.D., Gerasimenko O.V., et al. Activation of trypsinogen in large endocytic vacuoles of pancreatic acinar cells. Proceedings of the National Academy of Sciences of the United States of America 104 (2007) 5674-5679
56. Siemiatkowski M., Sienkiewicz-Jarosz H., Czlonkowska A.I., Bidzinski A., and Plaznik A. Effects of buspirone, diazepam, and zolpidem on open field behavior, and brain [3H]muscimol binding after buspirone pretreatment. Pharmacology, Biochemistry and Behavior 66 (2000) 645-651
57. Singh V.P., Bhagat L., Navina S., Sharif R., Dawra R., and Saluja A.K. PAR-2 protects against pancreatitis by stimulating exocrine secretion. Gut (2006)
58. Smith D.E., Johanson C.E., and Keep R.F. Peptide and peptide analog transport systems at the blood-CSF barrier. Advanced Drug Delivery Reviews 56 (2004) 1765-1791
59. Stroud L.M., O'Brien T.J., Jupp B., Wallengren C., and Morris M.J. Neuropeptide Y suppresses absence seizures in a genetic rat model. Brain Research 1033 (2005) 151-156
60. Sussmuth S.D., Brettschnieder J., Ludolph A.C., and Tumari H. Biochemical markers in CSF of ALS patients. Current Medicinal Chemistry 15 (2008) 1788-1801
61. Tamura H., Ishikawa Y., Hino N., Maeda M., Yoshida S., Kaku S., et al. Neuropsin is essential for early processes of memory acquisition and schaffer collateral long-term potentiation in adult mouse hippocampus in vivo. Journal of Physiology 570 (2006) 541-551
62. Tomimatsu Y., Idemoto S., Moriguchi S., Watanabe S., and Nakanishi H. Proteases involved in long-term potentiation. Life Sciences 72 (2002) 355-361
63. Vyas A., Jadhav S., and Chattarji S. Prolonged behavioral stress enhances synaptic connectivity in the basolateral amygdala. Neuroscience 143 (2006) 387-393
64. Wall P.M., and Messier C. Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior. Neuroscience and Biobehavioral Reviews 25 (2001) 275-286
65. Wang Y., Luo W., and Reiser G. Trypsin and trypsin-like proteases in the brain: Proteolysis and cellular functions. Cellular and Molecular Life Sciences 65 (2008) 237-252
66. Yang Z., Huang Y., Gan G., and Sawchuk R.J. Microdialysis evaluation of the brain distribution of stavudine following intranasal and intravenous administration to rats. Journal of Pharmaceutical Sciences 94 (2005) 1577-1588